BROW MEDICAL CENTRE
THE BROW, BURGESS HILLSTIA007
The percentage of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record in the preceding 12 months that an anti-platelet agent, or an anti-coagulant is being taken
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
STROKE 9 | 2005 | 55 | 58 | 94.8% | |
STROKE 9 | 2006 | 57 | 60 | 95.0% | |
Stroke 12 | 2007 | 80 | 86 | 93.0% | |
Stroke 12 | 2008 | 81 | 88 | 92.0% | |
Stroke 12 | 2009 | 84 | 91 | 92.3% | |
Stroke 12 | 2010 | 85 | 93 | 91.4% | |
STROKE 12 | 2011 | 93 | 100 | 93.0% | |
STROKE 12 | 2012 | 99 | 104 | 95.2% | |
STROKE 12 | 2013 | 90 | 95 | 94.7% | |
STIA007 | 2014 | 94 | 96 | 97.9% | |
STIA007 | 2015 | 109 | 112 | 97.3% | |
STIA007 | 2016 | 107 | 109 | 98.2% | |
STIA007 | 2017 | 119 | 122 | 97.5% | |
STIA007 | 2018 | 126 | 129 | 97.7% | |
STIA007 | 2019 | 128 | 131 | 97.7% | |
STIA007 | 2020 | 143 | 147 | 97.3% | |
STIA007 | 2021 | 135 | 136 | 99.3% | |
STIA007 | 2022 | 143 | 143 | 100.0% | |
STIA007 | 2023 | 140 | 143 | 97.9% |